Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity

Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity

US Patent 11135280 · Granted Oct 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Claudin 6 antibodies and uses thereof2025
Glucose transporter 4 antibodies, methods of making the same, and uses thereof2023
Immunogenic composition comprising a fusion peptide derived from superantigen to2023
Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and Lu2022
Immunogenic composition comprising a fusion peptide derived from superantigen to2022
Claudin 6 antibodies and uses thereof2022
Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fus2021
Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fus2021
Targeting immunological functions to the site of bacterial infections using cell2021
Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies dire2020
Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies dire2020
Targeting immunological functions to the site of bacterial infections using cell2019